Evidence map›Paper›PMID 29671588›Full record

ArticleJournal of natural products2018

Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.

Richard W Fitch, Barry B Snider, Quan Zhou, Bruce M Foxman, Anshul A Pandya, Jerrel L Yakel, Thao T Olson, Nour Al-Muhtasib, Yingxian Xiao, Kevin D Welch and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of natural products, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Naturally Occurring Organohalogen Compounds-A Comprehensive Review.Progress in the chemistry of organic natural products · 2023
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Richard W FitchDepartment of Chemistry and Physics , Indiana State University , Terre Haute , Indiana 47809 , United States.ORCID 0000-0002-4927-725X
Barry B SniderDepartment of Chemistry , Brandeis University MS 015 , Waltham , Massachusetts 02453 , United States.
Quan ZhouDepartment of Chemistry , Brandeis University MS 015 , Waltham , Massachusetts 02453 , United States.
Bruce M FoxmanDepartment of Chemistry , Brandeis University MS 015 , Waltham , Massachusetts 02453 , United States.ORCID 0000-0001-5707-8341
Anshul A PandyaNeurobiology Laboratory , National Institute of Environmental Health Sciences, NIH/DHHS , Research Triangle Park , North Carolina 27709 , United States.
Jerrel L YakelNeurobiology Laboratory , National Institute of Environmental Health Sciences, NIH/DHHS , Research Triangle Park , North Carolina 27709 , United States.
Thao T OlsonDepartment of Pharmacology and Physiology , Georgetown University , Washington , D.C. 20057 , United States.
Nour Al-MuhtasibDepartment of Pharmacology and Physiology , Georgetown University , Washington , D.C. 20057 , United States.
Yingxian XiaoDepartment of Pharmacology and Physiology , Georgetown University , Washington , D.C. 20057 , United States.
Kevin D WelchPoisonous Plant Research Laboratory, United States Department of Agriculture , Agricultural Research Service , Logan , Utah 84341 , United States.ORCID 0000-0002-5552-4894
Kip E PanterPoisonous Plant Research Laboratory, United States Department of Agriculture , Agricultural Research Service , Logan , Utah 84341 , United States.
Brandeis University · USGeorgetown University · USAgricultural Research Service · USNational Institute of Environmental Health Sciences · USIndiana State University · US

Funding

Modulation Of Neuronal Channels and Receptors in the BrainZIAES090089 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI YAKEL, JERREL L · 2009 to 2025
$42.2M
Synthesis and Optimization of Selective alpha4beta2 Neuronal nAChR DesensitizersU19DA027990 · NIDA · GEORGETOWN UNIVERSITY · PI BROWN, MILTON L. · 2010 to 2014
$4.3M
MODULATION OF NEURONAL LIGAND-GATED CHANNELS BY CALCIUM DEPENDENT MECHANISMSZ01ES090089 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI YAKEL, JERREL L · 1997 to 2008
$3.6M
High Throughput Screening for nAChRs: Cell Lines and Assay DevelopmentR21DA032489 · NIDA · GEORGETOWN UNIVERSITY · PI XIAO, YINGXIAN · 2011 to 2011
$243k
Intramural NIH HHS Z01 ES090089NIDA NIH HHS R21 DA032489NIDA NIH HHS U19 DA027990
6 · The paper itself

Abstract

Phantasmidine, a rigid congener of the well-known nicotinic acetylcholine receptor agonist epibatidine, is found in the same species of poison frog ( Epipedobates anthonyi). Natural phantasmidine was found to be a 4:1 scalemic mixture, enriched in the (2a R,4a S,9a S) enantiomer by chiral-phase LC-MS comparison to the synthetic enantiomers whose absolute configurations were previously established by Mosher's amide analysis. The major enantiomer has the opposite S configuration at the benzylic carbon to natural epibatidine, whose benzylic carbon is R. Pharmacological characterization of the synthetic racemate and separated enantiomers established that phantasmidine is ∼10-fold less potent than epibatidine, but ∼100-fold more potent than nicotine in most receptors tested. Unlike epibatidine, phantasmidine is sharply enantioselective in its activity and the major natural enantiomer whose benzylic carbon has the 4a S configuration is more active. The stereoselective pharmacology of phantasmidine is ascribed to its rigid and asymmetric shape as compared to the nearly symmetric conformations previously suggested for epibatidine enantiomers. While phantasmidine itself is too toxic for direct therapeutic use, we believe it is a useful platform for the development of potent and selective nicotinic agonists, which may have value as pharmacological tools.

Indexed as

AlkaloidsAmphibian VenomsAnimalsAnuraBridged Bicyclo Compounds, HeterocyclicHeterocyclic Compounds, Bridged-RingNicotineNicotinic AgonistsPoisonsPyridinesReceptors, NicotinicStereoisomerismAlkaloidsAmphibian VenomsBridged Bicyclo Compounds, HeterocyclicepibatidineHeterocyclic Compounds, Bridged-RingNicotineNicotinic AgonistsphantasmidinePoisonsPyridinesReceptors, Nicotinic

Identifiers

PMID29671588
PMCPMC7142328
OpenAlexW2802928506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.